OASI Bioresearch Foundation, Gobbi NPO, Milan, Italy.
Sports Health. 2012 Mar;4(2):162-72. doi: 10.1177/1941738111431801.
With increasing frequency, platelet-rich plasma (PRP) preparations have been used to treat cartilage lesions to regenerate tissue homeostasis and retard the progression of knee osteoarthritis (OA).
To determine the effectiveness of intra-articular PRP injections in active patients with knee OA and to evaluate clinical outcomes in patients with and without previous surgical treatment for cartilage lesions.
Case series.
Fifty patients with knee OA were followed for a minimum of 12 months. All were treated with 2 intra-articular injections of autologous PRP. Twenty-five patients had undergone a previous operative intervention for cartilage lesions, whereas 25 had not. Operated patients had undergone either cartilage shaving or microfracture. Multiple evaluative scores were collected at pretreatment and at 6 and 12 months posttreatment. The required sample of patients was determined beforehand by using statistical power analysis; International Knee Documentation Committee (subjective) score was defined as the primary parameter. A P value of less than 0.05 was considered statistically significant. General linear model-repeated measure test evaluated within-time improvement for each variable for all patients. Post hoc test with Bonferroni adjustment for multiple comparisons was performed to investigate the significance in improvement within time evaluations for each variable for the total sample. The differences in improvement between operated and nonoperated patients were also investigated, as were those between sexes.
All patients showed significant improvement in all scores at 6 and 12 months (P < 0.01) and returned to previous activities. No significant difference in improvement was found between the evaluated subgroups (P < 0.01).
The PRP treatment showed positive effects in patients with knee OA. Operated and nonoperated patients showed significant improvement by means of diminishing pain and improved symptoms and quality of life.
There are only a few studies of PRP treatment for cartilage on osteoarthritic knees. Different PRP products might be more or less appropriate to treat different types of tissues and pathologies. The clinical efficacy of PRP remains under debate, and a standardized protocol has not yet been established.
富含血小板的血浆(PRP)制剂越来越频繁地用于治疗软骨病变,以再生组织稳态并延缓膝骨关节炎(OA)的进展。
确定关节内 PRP 注射在活跃的膝 OA 患者中的有效性,并评估有和没有先前软骨病变手术治疗的患者的临床结果。
病例系列。
50 例膝 OA 患者随访至少 12 个月。所有患者均接受 2 次关节内自体 PRP 注射治疗。25 例患者曾接受过软骨病变的手术干预,而 25 例患者则未接受。手术患者接受了软骨削磨或微骨折术。在治疗前和治疗后 6 个月和 12 个月收集了多个评估评分。通过使用统计功效分析预先确定了所需的患者样本量;国际膝关节文献委员会(主观)评分被定义为主要参数。P 值小于 0.05 被认为具有统计学意义。对所有患者进行了一般线性模型重复测量检验,以评估每个变量的随时间改善情况。进行了事后检验,并用 Bonferroni 调整进行了多次比较,以调查每个变量在总样本中随时间改善的显著性。还研究了手术和非手术患者之间以及男女之间改善的差异。
所有患者在 6 个月和 12 个月时所有评分均显著改善(P < 0.01),并恢复到以前的活动水平。在评估的亚组之间未发现改善的显著差异(P < 0.01)。
PRP 治疗对膝 OA 患者显示出积极的效果。手术和非手术患者通过减轻疼痛和改善症状和生活质量显示出显著的改善。
只有少数关于 PRP 治疗骨关节炎膝关节软骨的研究。不同的 PRP 产品可能更适合或不太适合治疗不同类型的组织和病理。PRP 的临床疗效仍存在争议,尚未建立标准化方案。